Rapid improvement in speech and motor function, two years after stroke following local anti-TNF administration at TransBarrier® is documented. Individual results can vary. Chronic neurological dysfunction produced by stroke has long been thought to be irreversible. A new scientific discovery by TransBarrier®, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.
This new patented treatment is available for new patients at TransBarrier®. For further information, please call TransBarrier® in Los Angeles at (310) 479-0107, or in Boca Raton at (561) 353-9707.
Please see: CNS Drugs. 2011 Feb;25(2):145-155.
Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. The method utilized for this indication is off-label. Please see the Terms of Use. Copyright 2015 TransBarrier®, all rights reserved. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583, all assigned to TACT IP, LLC; and Australian patent 758523.